HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Josbert M Metselaar Selected Research

prednisolone phosphate

1/2022Liposomal drug delivery system for anti-inflammatory treatment after cataract surgery: a phase I/II clinical trial.
1/2018Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis.
1/2017Liposomal Treatment of Experimental Arthritis Can Be Monitored Noninvasively with a Radiolabeled Anti-Fibroblast Activation Protein Antibody.
7/2008Liposomal glucocorticoids as tumor-targeted anti-angiogenic nanomedicine in B16 melanoma-bearing mice.
2/2008Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue.
6/2006Anti-angiogenic effects of liposomal prednisolone phosphate on B16 melanoma in mice.
2/2005Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice.
11/2003A novel family of L-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity.
7/2003Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Josbert M Metselaar Research Topics

Disease

19Neoplasms (Cancer)
04/2022 - 02/2005
18Inflammation (Inflammations)
01/2022 - 07/2003
7Arthritis (Polyarthritis)
01/2018 - 01/2002
6Atherosclerosis
09/2017 - 12/2010
5Rheumatoid Arthritis
01/2022 - 01/2006
5Hypersensitivity (Allergy)
01/2022 - 05/2013
5Experimental Arthritis
01/2018 - 07/2003
4Prostatic Neoplasms (Prostate Cancer)
10/2021 - 05/2014
4Atherosclerotic Plaque (Atheroma)
01/2016 - 12/2010
4Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
10/2011 - 08/2003
4Multiple Sclerosis
10/2011 - 08/2003
3Multiple Myeloma
10/2020 - 01/2019
2Reperfusion Injury
01/2022 - 01/2018
2Neoplasm Metastasis (Metastasis)
01/2021 - 06/2015
2Pulmonary Hypertension
10/2019 - 12/2014
2Carcinoma (Carcinomatosis)
05/2014 - 02/2005
2Experimental Melanoma
07/2008 - 06/2006
1Hypoxia (Hypoxemia)
01/2022
1Ischemia
01/2022
1Cataract (Cataracts)
01/2022
1Psoriasis (Pustulosis Palmaris et Plantaris)
07/2021
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2021
1Stomach Neoplasms (Stomach Cancer)
01/2021
1Fistula
08/2020
1COVID-19
01/2020
1Hematologic Neoplasms (Hematological Malignancy)
01/2019
1Adenocarcinoma
01/2019
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2019
1Kidney Diseases (Kidney Disease)
01/2018
1Uveitis
01/2018
1Myocardial Infarction
10/2017
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2017
1Breast Neoplasms (Breast Cancer)
01/2016
1Hyperplasia
01/2016
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2016
1Arteriovenous Fistula
01/2016

Drug/Important Bio-Agent (IBA)

31Liposomes (Liposome)IBA
01/2022 - 01/2002
14Prednisolone (Predate)FDA LinkGeneric
01/2022 - 08/2003
14Pharmaceutical PreparationsIBA
06/2020 - 02/2005
14GlucocorticoidsIBA
01/2019 - 01/2002
9prednisolone phosphateFDA LinkGeneric
01/2022 - 07/2003
5Dexamethasone (Maxidex)FDA LinkGeneric
10/2021 - 01/2014
4Proteins (Proteins, Gene)FDA Link
01/2018 - 12/2010
3SteroidsIBA
01/2022 - 01/2018
3MicellesIBA
01/2021 - 01/2014
3PolymersIBA
06/2020 - 11/2003
3Therapeutic UsesIBA
01/2018 - 10/2011
3Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
09/2003 - 07/2003
2ProdrugsIBA
01/2022 - 01/2014
2MethylprednisoloneFDA LinkGeneric
01/2022 - 06/2008
2Ophthalmic Solutions (Eye Drops)IBA
01/2022 - 12/2021
2Docetaxel (Taxotere)FDA Link
01/2021 - 01/2016
2Bortezomib (Velcade)FDA Link
10/2020 - 12/2019
2Phosphates (Orthophosphate)IBA
01/2018 - 09/2011
2AntigensIBA
01/2018 - 07/2015
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2017 - 12/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2003 - 08/2003
1Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2022
1Carboplatin (JM8)FDA LinkGeneric
04/2022
1Cisplatin (Platino)FDA LinkGeneric
04/2022
1Coordination ComplexesIBA
04/2022
1QuercetinIBA
01/2022
1DEPOIBA
01/2022
1GlucuronidaseIBA
01/2022
1EnzymesIBA
01/2022
1Immunomodulating AgentsIBA
01/2021
1Proteasome InhibitorsIBA
12/2019
1Thromboxane B2IBA
10/2019
1GemcitabineFDA Link
01/2019
1dexamethasone 21-phosphateFDA LinkGeneric
01/2019
1Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
01/2018
1Interleukin-22 (IL-22)IBA
01/2018
1BerberineIBA
10/2017
1Biological ProductsIBA
09/2017
1Apolipoproteins E (ApoE)IBA
09/2017
1Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA
09/2017
1HDL LipoproteinsIBA
09/2017
1Simvastatin (Zocor)FDA LinkGeneric
09/2017
1ApolipoproteinsIBA
09/2017
1AsparagineIBA
01/2017
1Asparaginase (Elspar)FDA Link
01/2017
1LipidsIBA
01/2016
1Fish OilsIBA
01/2016
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2016
1Fatty Acids (Saturated Fatty Acids)IBA
01/2016
1Docosahexaenoic AcidsIBA
01/2016
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
01/2016
1N 30IBA
07/2015
1Drug CarriersIBA
06/2015
1Complement System Proteins (Complement)IBA
12/2014

Therapy/Procedure

15Therapeutics
04/2022 - 07/2003
5Intravenous Administration
10/2019 - 07/2003
3Drug Therapy (Chemotherapy)
01/2021 - 05/2014
2Castration
10/2021 - 05/2014
2Aftercare (After-Treatment)
01/2017 - 07/2003
1Immunotherapy
04/2022
1Lasers (Laser)
01/2022
1Transplantation
07/2021
1Decompression
01/2019
1Renal Dialysis (Hemodialysis)
01/2016